Promises and forecasts attributed to LG Chem in news reports, sealed when reported. A record shows what was reported as said, with the original link; it is not a judgement of the person.
LG Chem said Wednesday it aims to begin clinical development of a personalized mRNA cancer vaccine in 2029, leveraging artificial intelligence to accelerate drug discovery and identify patients most likely to benefit from treatment.
OPEN · DUE 31 DEC 2029said 21 Oct 2026Forecastrecord →